About 12 results found for searched term "BMS-37" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1682 | BMS-777607 | c-Met |
| BMS 817378; CAS# 1025720-94-8 | ||
| BMS-777607 is a selective and potent small-molecule met kinase inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively. | ||
| M3485 | BMS-378806 | HIV Protease |
| BMS 806 | ||
| BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus. | ||
| M7671 | BMS-823778 | Hydroxysteroid dehydrogenase |
| BMS-823778 is an orally available potent and selective inhibitor of 11-β-hydroxysteroid-dehyd |
||
| M21871 | BMS 433796 | Others |
| BMS 433796 | ||
| M25151 | Beludavimab | Anti-infection |
| BMS 4182137; VIR 7832 | ||
| Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM. | ||
| M29962 | Fosravuconazole | Antifungal |
| BMS-379224; E-1224 | ||
| Fosravuconazole (BMS-379224), a proagent of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole can be used for candidiasis, onychomycosis and parasitemia research. | ||
| M30271 | BMS-433771 dihydrochloride hydrate | RSV |
| BMS-433771 dihydrochloride hydrate is a potent orally active inhibitor of respiratory syncytial virus (RSV). BMS-433771 dihydrochloride hydrate is active against both A and B groups of RSV, with an average EC50 of 20 nM. BMS-433771 dihydrochloride hydrate can be used for the research of respiratory tract disease. | ||
| M30272 | BMS-433771 | RSV |
| BMS-433771 is a potent orally active inhibitor of respiratory syncytial virus (RSV). BMS-433771 is active against both A and B groups of RSV, with an average EC50 of 20 nM. BMS-433771 can be used for the research of respiratory tract disease. | ||
| M30883 | Fosravuconazole L-lysine ethanolate | Antifungal |
| BMS-379224 L-lysine ethanolate; E-1224 L-lysine ethanolate | ||
| Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate), a proagent of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole L-lysine ethanolate can be used for candidiasis, onychomycosis and parasitemia research. | ||
| M31302 | BMS-37 | PD-1/PD-L1 |
| BMS-37 is a diaryl ether small molecule and a PD-1/PD-L1 immune checkpoint inhibitor. In addition, BMS-37 can also act as a PD-L1 ligand to synthesize PROTAC molecules. | ||
| M49441 | BMS-986337 | LPL Receptor |
| BMS-986337 is a lysophosphatidic acid receptor (LPAR1) antagonist for studies related to pulmonary fibrosis. | ||
| M54763 | BMS-817378 | c-Met |
| BMS817378 | ||
| BMS-817378 is a potent and selective inhibitor of MET with IC50 of 1.7 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
